Skip to main content
SpringerLink
Log in

Empfehlungen der European Stroke Initiative (EUSI) zur Behandlung des ischämischen Schlaganfalls — Aktualisierung 2003

Teil 2: Prävention und Rehabilitation

  • Aktuelles
  • Published:
Der Nervenarzt Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Literatur

  1. Abbott RD, Yin Y, Reed DM et al. (1986) Risk of stroke in male cigarette smokers. N Engl J Med 315(12):717–720

    CAS  PubMed  Google Scholar 

  2. Adams HP, Brott TG, Crowell RM et al. (1994) Guidelines for the management of patients with acute ischemic stroke. Stroke 25(9):1901–1914

    PubMed  Google Scholar 

  3. Algra A, van Gijn J (1996) Aspirin at any dose above 30 mg offers only modest protection after cerebral ischaemia. J Neurol Neurosurg Psychiatry 60(2):197–199

    CAS  PubMed  Google Scholar 

  4. ALLHAT investigators (2002) Major outcomes in moderately hypercholesterolemic, hypertensive patients randomized to pravastatin vs usual care: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT-LLT). Jama 288(23):2998–3007

    PubMed  Google Scholar 

  5. American Diabetes Association (2000) Aspirin treatment in diabetes. Diabetes Care 23:61–62

    Google Scholar 

  6. Antiplatelet Trialists Collaboration (2002) Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ 324(7329):71–86

    PubMed  Google Scholar 

  7. Baker WH, Howard VJ, Howard G et al. (2000) Effect of contralateral occlusion on long-term efficacy of endarterectomy in the asymptomatic carotid atherosclerosis study (ACAS). ACAS Investigators. Stroke 31(10):2330–2334

    CAS  PubMed  Google Scholar 

  8. Barnett HJ, Taylor DW, Eliasziw M et al. (1998) Benefit of carotid endarterectomy in patients with symptomatic moderate or severe stenosis. North American Symptomatic Carotid Endarterectomy Trial Collaborators. N Engl J Med 339(20):1415–1425

    CAS  PubMed  Google Scholar 

  9. Benavente O, Moher D, Pham B (1998) Carotid endarterectomy for asymptomatic carotid stenosis: a meta-analysis. BMJ 317(7171):1477–1480

    CAS  PubMed  Google Scholar 

  10. Bernabei R, Landi F, Gambassi G et al. (1998) Randomised trial of impact of model of integrated care and case management for older people living in the community. BMJ 316(7141):1348–1351

    CAS  PubMed  Google Scholar 

  11. Bhatt DL, Kapadia SR, Yadav JS et al. (2000) Update on clinical trials of antiplatelet therapy for cerebrovascular diseases. Cerebrovasc Dis 10(Suppl 5):34–40

    Google Scholar 

  12. Cannegieter SC, Rosendaal FR, Wintzen AR et al. (1995) Optimal oral anticoagulant therapy in patients with mechanical heart valves. N Engl J Med 333(1):11–17

    CAS  PubMed  Google Scholar 

  13. CAPRIE Steering Committee (1996) A randomised, blinded trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). Lancet 348:1329–1339

    Article  PubMed  Google Scholar 

  14. Cavatas Group (2001) Endovascular versus surgical treatment in patients with carotid stenosis in the Carotid and Vertebral Artery Transluminal Angioplasty Study (CAVATAS): a randomised trial. Lancet 357(9270):1729–1737

    PubMed  Google Scholar 

  15. Colditz GA, Bonita R, Stampfer MJ et al. (1988) Cigarette smoking and risk of stroke in middle-aged women. N Engl J Med 318(15):937–941

    CAS  PubMed  Google Scholar 

  16. Dahlof B, Devereux RB, Kjeldsen SE et al. (2002) Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol. Lancet 359(9311):995–1003

    Article  PubMed  Google Scholar 

  17. De Gaetano G (2001) Low-dose aspirin and vitamin E in people at cardiovascular risk: a randomised trial in general practice. Collaborative Group of the Primary Prevention Project. Lancet 357(9250):89–95

    PubMed  Google Scholar 

  18. Di Mascio R, Marchioli R, Tognoni G (2000) Cholesterol reduction and stroke occurrence: an overview of randomized clinical trials. Cerebrovasc Dis 10(2):85–92

    PubMed  Google Scholar 

  19. Diener HC, Ringelstein EB, von Kummer R et al. (2001) Treatment of acute ischemic stroke with the low-molecular-weight heparin certoparin: results of the TOPAS trial. Therapy of Patients With Acute Stroke (TOPAS) Investigators. Stroke 32(1):22–29

    CAS  PubMed  Google Scholar 

  20. Dressler FA, Craig WR, Castello R et al. (1998) Mobile aortic atheroma and systemic emboli: efficacy of anticoagulation and influence of plaque morphology on recurrent stroke. J Am Coll Cardiol 31(1):134–138

    CAS  PubMed  Google Scholar 

  21. Echiverri HC, Rubino FA, Gupta SR et al. (1989) Fusiform aneurysm of the vertebrobasilar arterial system. Stroke 20(12):1741–1747

    CAS  PubMed  Google Scholar 

  22. ETDRS Investigators (1992) Aspirin effects on mortality and morbidity in patients with diabetes mellitus. Early Treatment Diabetic Retinopathy Study report 14. JAMA 268(10):1292–1300

    PubMed  Google Scholar 

  23. European Stroke Initiative (2000) European Stroke Initiative recommendations for stroke management. European Stroke Council, European Neurological Society and European Federation of Neurological Societies. Cerebrovasc Dis 10(5):335–351

    PubMed  Google Scholar 

  24. Executive Committee for the Asymptomatic Carotid Atherosclerosis Study (1995) Endarterectomy for asymptomatic carotid artery stenosis. JAMA 273(18):1421–1428

    PubMed  Google Scholar 

  25. Farrell B, Godwin J, Richards S et al. (1991) The United Kingdom transient ischaemic attack (UK-TIA) aspirin trial: final results. J Neurol Neurosurg Psychiatry 54(12):1044–1054

    CAS  PubMed  Google Scholar 

  26. Fuster V, Ryden LE, Asinger RW et al. (2001) ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation: executive summary. A report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the European Society of Cardiology Committee for practice guidelines and policy conferences (committee to develop guidelines for the management of patients with atrial fibrillation) developed in collaboration with the North American Society of Pacing and Electrophysiology. Circulation 104(17):2118–2150

    CAS  PubMed  Google Scholar 

  27. Grady D, Herrington D, Bittner V et al. (2002) Cardiovascular disease outcomes during 6.8 years of hormone therapy: Heart and Estrogen/progestin Replacement Study follow-up (HERS II). JAMA 288(1):49–57

    PubMed  Google Scholar 

  28. Grodstein F, Manson JE, Stampfer MJ (2001) Postmenopausal hormone use and secondary prevention of coronary events in the nurses’ health study. a prospective, observational study. Ann Intern Med 135(1):1–8

    CAS  Google Scholar 

  29. Gueyffier F, Boissel JP, Boutitie F et al. (1997) Effect of antihypertensive treatment in patients having already suffered from stroke. Gathering the evidence. The INDANA (INdividual Data ANalysis of Antihypertensive intervention trials) Project Collaborators. Stroke 28(12):2557–2562

    CAS  PubMed  Google Scholar 

  30. Hankey GJ, Warlow CP (1999) Treatment and secondary prevention of stroke: evidence, costs, and effects on individuals and populations. Lancet 354(9188):1457–1463

    CAS  PubMed  Google Scholar 

  31. Hansson L, Zanchetti A, Carruthers SG et al. (1998) Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group. Lancet 351(9118):1755–1762

    CAS  PubMed  Google Scholar 

  32. Hart RG, Sherman DG, Easton JD et al. (1998) Prevention of stroke in patients with nonvalvular atrial fibrillation. Neurology 51(3):674–681

    CAS  PubMed  Google Scholar 

  33. Hart RG, Halperin JL, McBride R et al. (2000) Aspirin for the primary prevention of stroke and other major vascular events: meta-analysis and hypotheses. Arch Neurol 57(3):326–332

    CAS  PubMed  Google Scholar 

  34. He K, Rimm EB, Merchant A et al. (2002) Fish consumption and risk of stroke in men. JAMA 288(24):3130–3136

    CAS  PubMed  Google Scholar 

  35. Heart Protection Study Collaborative Group (2002) MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial. Lancet 360(9326):7–22

    Article  PubMed  Google Scholar 

  36. Hesse S (2001) Locomotor therapy in neurorehabilitation. NeuroRehabilitation 16(3):133–139

    CAS  PubMed  Google Scholar 

  37. Hughes RA, Barnes MP, Baron JC et al. (2001) Guidance for the preparation of neurological management guidelines by EFNS scientific task forces. Eur J Neurol 8(6):549–550

    CAS  PubMed  Google Scholar 

  38. Indredavik B, Bakke F, Solberg R et al. (1991) Benefit of a stroke unit: a randomized controlled trial. Stroke 22(8):1026–1031

    CAS  PubMed  Google Scholar 

  39. Inzitari D, Eliasziw M, Gates P et al. (2000) The causes and risk of stroke in patients with asymptomatic internal-carotid-artery stenosis. North American Symptomatic Carotid Endarterectomy Trial Collaborators. N Engl J Med 342(23):1693–1700

    Article  CAS  PubMed  Google Scholar 

  40. Johansson BB (2000) Brain plasticity and stroke rehabilitation. The Willis lecture. Stroke 31(1):223–230

    CAS  PubMed  Google Scholar 

  41. Jorgensen HS, Kammersgaard LP, Houth J et al. (2000) Who benefits from treatment and rehabilitation in a stroke Unit? A community-based study. Stroke 31(2):434–439

    CAS  PubMed  Google Scholar 

  42. Kaste M, Palomaki H, Sarna S (1995) Where and how should elderly stroke patients be treated? A randomized trial. Stroke 26(2):249–253

    CAS  PubMed  Google Scholar 

  43. Kawachi I, Colditz GA, Stampfer MJ et al. (1993) Smoking cessation and decreased risk of stroke in women. JAMA 269(2):232–236

    Article  CAS  PubMed  Google Scholar 

  44. Lee IM, Hennekens CH, Berger K et al. (2001) Exercise and risk of stroke in male physicians. Cochrane Database Syst Rev 2(1):1–6

    CAS  Google Scholar 

  45. Lewington S, Clarke R, Qizilbash N et al. (2002) Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet 360(9349):1903–1913

    Article  PubMed  Google Scholar 

  46. Mas JL, Arquizan C, Lamy C et al. (2001) Recurrent cerebrovascular events associated with patent foramen ovale, atrial septal aneurysm, or both. N Engl J Med 345(24):1740–1746

    Article  CAS  PubMed  Google Scholar 

  47. Meade T (1998) Low dose warfarin and aspirin in preventing IHD. Practitioner 242(1592):799–803

    CAS  PubMed  Google Scholar 

  48. Miltner WH, Bauder H, Sommer M et al. (1999) Effects of constraint-induced movement therapy on patients with chronic motor deficits after stroke: a replication. Stroke 30(3):586–592

    CAS  PubMed  Google Scholar 

  49. Mohr JP, Thompson JL, Lazar RM et al. (2001) A comparison of warfarin and aspirin for the prevention of recurrent ischemic stroke. N Engl J Med 345(20):1444–1451

    CAS  PubMed  Google Scholar 

  50. Morley J, Marinchak R, Rials SJ et al. (1996) Atrial fibrillation, anticoagulation, and stroke. Am J Cardiol 77(3):38a-44a

    CAS  PubMed  Google Scholar 

  51. Neal B, MacMahon S, Chapman N (2000) Effects of ACE inhibitors, calcium antagonists, and other blood-pressure-lowering drugs: results of prospectively designed overviews of randomised trials. Blood Pressure Lowering Treatment Trialists’ Collaboration. Lancet 356(9246):1955–1964

    CAS  PubMed  Google Scholar 

  52. PATS Collaborating Group (1995) Post-stroke antihypertensive treatment study. A preliminary result. Chin Med J (Engl) 108(9):710–717

    Google Scholar 

  53. Peto R, Gray R, Collins R et al. (1988) Randomised trial of prophylactic daily aspirin in British male doctors. Br Med J (Clin Res Ed) 296(6618):313–316

    Google Scholar 

  54. PROGRESS collaborative group (2001) Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6,105 individuals with previous stroke or transient ischaemic attack. Lancet 358(9287):1033–1041

    PubMed  Google Scholar 

  55. Reynolds K, Lewis B, Nolen JD et al. (2003) Alcohol consumption and risk of stroke: a meta-analysis. Jama 289(5):579–588

    Article  PubMed  Google Scholar 

  56. Rothwell PM, Eliasziw M, Gutnikov SA et al. (2003) Analysis of pooled data from the randomised controlled trials of endarterectomy for symptomatic carotid stenosis. Lancet 361(9352):107–116

    Article  CAS  PubMed  Google Scholar 

  57. Roubin GS, New G, Iyer SS et al. (2001) Immediate and late clinical outcomes of carotid artery stenting in patients with symptomatic and asymptomatic carotid artery stenosis: a 5-year prospective analysis. Circulation 103(4):532–537

    CAS  PubMed  Google Scholar 

  58. Rubins HB, Robins SJ, Collins D et al. (1999) Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol. Veterans Affairs High-Density Lipoprotein Cholesterol Intervention Trial Study Group. N Engl J Med 341(6):410–418

    Article  CAS  PubMed  Google Scholar 

  59. Shepherd J, Blauw GJ, Murphy MB et al. (2002) Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial. Lancet 360(9346):1623–1630

    Article  CAS  PubMed  Google Scholar 

  60. Shinton R, Beevers G (1989) Meta-analysis of relation between cigarette smoking and stroke. BMJ 298(6676):789–794

    CAS  PubMed  Google Scholar 

  61. Sivenius J, Pyorala K, Heinonen OP et al. (1985) The significance of intensity of rehabilitation of stroke—a controlled trial. Stroke 16(6):928–931

    CAS  PubMed  Google Scholar 

  62. Staessen JA, Wang JG, Thijs L (2001) Cardiovascular protection and blood pressure reduction: a meta-analysis. Lancet 358(9290):1305–1315

    Article  CAS  PubMed  Google Scholar 

  63. Steering Committee of the Physicians’ Health Study Research Group (1989) Final report on the aspirin component of the ongoing Physicians’ Health Study. N Engl J Med 321(3):129–135

    PubMed  Google Scholar 

  64. Strand T, Asplund K, Eriksson S et al. (1985) A non-intensive stroke unit reduces functional disability and the need for long-term hospitalization. Stroke 16(1):29–34

    CAS  PubMed  Google Scholar 

  65. Straus SE, Majumdar SR, McAlister FA (2002) New evidence for stroke prevention: scientific review. JAMA 288(11):1388–1395

    PubMed  Google Scholar 

  66. Stroke Unit Trialists’ Collaboration (2002) Organised inpatient (stroke unit) care for stroke. Cochrane Database Syst Rev 1

  67. Taub E, Miller NE, Novack TA et al. (1993) Technique to improve chronic motor deficit after stroke. Arch Phys Med Rehabil 74(4):347–354

    CAS  PubMed  Google Scholar 

  68. The Dutch TIA Trial Study Group (1991) A comparison of two doses of aspirin (30 mg vs. 283 mg a day) in patients after a transient ischemic attack or minor ischemic stroke. N Engl J Med 325(18):1261–1266

    PubMed  Google Scholar 

  69. The EC/IC Bypass Study Group (1985) Failure of extracranial-intracranial arterial bypass to reduce the risk of ischemic stroke. Results of an international randomized trial. N Engl J Med 313(19):1191–1200

    PubMed  Google Scholar 

  70. The European Atrial Fibrillation Trial Study Group (1995) Optimal oral anticoagulant therapy in patients with nonrheumatic atrial fibrillation and recent cerebral ischemia. N Engl J Med 333(1):5–10

    PubMed  Google Scholar 

  71. The European Carotid Surgery Trialists Collaborative Group (1995) Risk of stroke in the distribution of an asymptomatic carotid artery. Lancet 345(8944):209–212

    Article  PubMed  Google Scholar 

  72. The North American Symptomatic Carotid Endarterectomy Trial Collaborators (1991) Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis. North American Symptomatic Carotid Endarterectomy Trial Collaborators. N Engl J Med 325(7):445–453

    PubMed  Google Scholar 

  73. The Stroke Prevention in Reversible Ischemia Trial (SPIRIT) Study Group (1997) A randomized trial of anticoagulants versus aspirin after cerebral ischemia of presumed arterial origin. Ann Neurol 42(6):857–865

    PubMed  Google Scholar 

  74. Turner RC, Cull CA, Frighi V et al. (1999) Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus: progressive requirement for multiple therapies (UKPDS 49). UK Prospective Diabetes Study (UKPDS) Group. JAMA 281(21):2005–2012

    PubMed  Google Scholar 

  75. Viscoli CM, Brass LM, Kernan WN et al. (2001) A clinical trial of estrogen-replacement therapy after ischemic stroke. N Engl J Med 345(17):1243–1249

    Google Scholar 

  76. Wannamethee SG, Shaper AG, Whincup PH et al. (1995) Smoking cessation and the risk of stroke in middle-aged men. JAMA 274(2):155–160

    CAS  PubMed  Google Scholar 

  77. Warlow C (1991) MRC European Carotid Surgery Trial: interim results for symptomatic patients with severe (70–99%) or with mild (0–29%) carotid stenosis. European Carotid Surgery Trialists’ Collaborative Group. Lancet 337(8752):1235–1243

    PubMed  Google Scholar 

  78. Werner C, Bardeleben A, Mauritz KH et al. (2002) Treadmill training with partial body weight support and physiotherapy in stroke patients: a preliminary comparison. Eur J Neurol 9(6):639–644

    CAS  PubMed  Google Scholar 

  79. WOSCOP study group (1998) Influence of pravastatin and plasma lipids on clinical events in the West of Scotland Coronary Prevention Study. Circulation 97(15):1440–1445

    PubMed  Google Scholar 

  80. Yusuf S, Sleight P, Pogue J et al. (2000) Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. N Engl J Med 342(3):145–153

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Neurologische Universitätsklinik Heidelberg, Heidelberg, Deutschland

    Sonja Külkens, Peter Arthur Ringleb &  Werner Hacke

  2. Neurologische Universitätsklinik Heidelberg, Im Neuenheimer Feld 400, 69120, Heidelberg, Deutschland

    Werner Hacke

Authors
  1. Sonja Külkens
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Peter Arthur Ringleb
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Werner Hacke
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Werner Hacke.

Additional information

Für das Executive- und Writing-Komitee der EUSI (siehe Anhang).

Anhang

Anhang

Mitglieder des EUSI-Exekutive-Komitees

  • Werner Hacke, Heidelberg, Deutschland

  • Markku Kaste, Helsinki, Finnland

  • Julien Bogousslavsky, Lausanne, Schweiz

  • Michael Brainin, Maria Gugging, Österreich

  • Angel Chamorro, Barcelona, Spanien

  • Kennedy Lees, Glasgow, Großbritannien

  • Didier Leys, Lille, Frankreich

  • Hubert Kwiecinski, Warschau, Polen

  • Danilo Toni, Rom, Italien

Mitglieder der EUSI-Writing-Group

  • Tom Skyhoj Olsen, Kopenhagen, Dänemark

  • Peter Langhorne, Glasgow, Großbritannien

  • Hans Christoph Diener, Essen, Deutschland

  • Michael Hennerici, Mannheim, Deutschland

  • Jose Ferro, Lissabon, Portugal

  • Johani Sivenius, Kuopiu, Finnland

  • Nils Gunnar Wahlgren, Stockholm, Schweden

  • Philip Bath, Nottingham, Großbritannien

Rights and permissions

Reprints and permissions

About this article

Cite this article

Külkens, S., Ringleb, P.A. & Hacke, W. Empfehlungen der European Stroke Initiative (EUSI) zur Behandlung des ischämischen Schlaganfalls — Aktualisierung 2003 . Nervenarzt 75, 380–388 (2004). https://doi.org/10.1007/s00115-003-1669-0

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00115-003-1669-0

Search

Navigation